SRRK

Scholar Rock Holding Corp

Biological Products, (No Diagnostic Substances)NasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

97

Buys

9

Sells

73

Largest Trade

$1M+

Insiders

22

Institutional Funds

215

Inst. Value

$1M+

Activist Filings

35

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Qatanani MoCHIEF SCIENTIFIC O…SELL$100K–$500K8K$47.07Feb 25, 2026
Qatanani MoCHIEF SCIENTIFIC O…SELL$500K+15K$46.71Jan 23, 2026
Qatanani MoCHIEF SCIENTIFIC O…SELL$100K–$500K8K$44.48Jan 22, 2026
Parlavecchio CarynCHROSELL$100K–$500K7K$44.48Jan 22, 2026
Marantz Jing L.CHIEF MEDICAL OFFI…SELL$100K–$500K6K$44.48Jan 22, 2026
Ho JunlinGENERAL COUNSELSELL$100K–$500K8K$44.48Jan 22, 2026
Qatanani MoCHIEF SCIENTIFIC O…SELL$500K+13K$45.20Jan 16, 2026
Qatanani MoCHIEF SCIENTIFIC O…EXERCISE$100K–$500K13K$18.53Jan 16, 2026
Sinha VikasCFOSELL$500K+17K$42.70Jan 16, 2026
Woods KeithCOOSELL$500K+17K$42.70Jan 16, 2026
Vaishnaw AkshayPresident of R&DSELL$500K+20K$42.70Jan 16, 2026
Hallal DavidCEOSELL$1M+57K$42.70Jan 16, 2026
Peng KatieDirectorSELL$15K–$50K1K$44.09Dec 18, 2025
AKKARAJU SRINIVASDirectorBUY$1M+30K$39.92Dec 17, 2025
Qatanani MoCHIEF SCIENTIFIC O…SELL$1M+136K$45.21Dec 5, 2025
Qatanani MoCHIEF SCIENTIFIC O…EXERCISE$1M+136K$21.21Dec 5, 2025
Qatanani MoCHIEF SCIENTIFIC O…SELL$100K–$500K3K$30.67Sep 24, 2025
Peng KatieDirectorSELL$15K–$50K1K$32.53Sep 17, 2025
Qatanani MoCHIEF SCIENTIFIC O…SELL$100K–$500K3K$33.52Sep 17, 2025
FLIER JEFFREY S.DirectorSELL$100K–$500K11K$40.02Jul 18, 2025
Qatanani MoCHIEF SCIENTIFIC O…SELL$500K+24K$34.44Jul 11, 2025
FLIER JEFFREY S.DirectorEXERCISE$100K–$500K20K$21.62Jun 25, 2025
FLIER JEFFREY S.DirectorSELL$1M+31K$32.58Jun 25, 2025
Peng KatieDirectorSELL$50K–$100K3K$31.97Jun 17, 2025
Qatanani MoCHIEF SCIENTIFIC O…SELL$100K–$500K4K$32.00Jun 17, 2025
Parlavecchio CarynCHROSELL$100K–$500K6K$32.00Jun 17, 2025
Ho JunlinGENERAL COUNSELSELL$100K–$500K7K$32.00Jun 17, 2025
FLIER JEFFREY S.DirectorSELL$100K–$500K6K$29.73May 30, 2025
Burow KristinaDirectorSELL$100K–$500K5K$29.72May 30, 2025
Gilman MichaelDirectorSELL$100K–$500K3K$29.72May 30, 2025
Brudnick RichardDirectorSELL$100K–$500K6K$29.72May 30, 2025
Reed JoshuaDirectorSELL$100K–$500K5K$29.72May 30, 2025
Vaishnaw AkshayPresident of R&DSELL$100K–$500K7K$29.72May 30, 2025
Sacco TraceyChief Commercial O…SELL$100K–$500K5K$32.83Apr 29, 2025
Sacco TraceyChief Commercial O…EXERCISE$50K–$100K5K$10.00Apr 29, 2025
Sacco TraceyChief Commercial O…SELL$100K–$500K7K$33.08Mar 25, 2025
Sacco TraceyChief Commercial O…EXERCISE$50K–$100K5K$10.00Mar 25, 2025
Moore ErinInterim PFO and PAOSELL$100K–$500K14K$33.12Mar 25, 2025
Moore ErinInterim PFO and PAOEXERCISE$100K–$500K14K$17.33Mar 25, 2025
Peng KatieDirectorSELL$15K–$50K1K$34.42Mar 19, 2025
Myles Edward HCOO & CFOSELL$1M+142K$35.62Mar 12, 2025
Myles Edward HCOO & CFOEXERCISE$1M+113K$13.60Mar 12, 2025
Qatanani MoCHIEF SCIENTIFIC O…EXERCISE$100K–$500K48K$10.19Feb 21, 2025
Qatanani MoCHIEF SCIENTIFIC O…SELL$1M+73K$37.37Feb 21, 2025
Parlavecchio CarynCHROSELL$100K–$500K5K$36.83Feb 20, 2025
Myles Edward HCOO & CFOSELL$100K–$500K8K$36.83Feb 20, 2025
Ho JunlinGENERAL COUNSELSELL$100K–$500K6K$36.83Feb 20, 2025
Backstrom Jay T.CHIEF EXECUTIVE OF…SELL$500K+18K$36.83Feb 20, 2025
Backstrom Jay T.CHIEF EXECUTIVE OF…SELL$500K+22K$44.20Jan 21, 2025
Marantz Jing L.CHIEF MEDICAL OFFI…SELL$100K–$500K6K$44.20Jan 21, 2025
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Wellington Management Group LLP

SC 13G · Feb 10, 2026

5.6%

5.8M shares

T. Rowe Price Associates, Inc.

SC 13G/A · Nov 14, 2025

7.2%

6.9M shares

Samsara BioCapital, L.P.

SC 13D/A · Oct 8, 2025

6.6%

6.4M shares

T. Rowe Price Associates, Inc.

SC 13G/A · Aug 14, 2025

9.2%

8.8M shares

Redmile Group, LLC

SC 13G/A · Feb 15, 2025

9.9%

9.9M shares

Invus Public Equities, L.P.

SC 13G/A · Feb 12, 2025

11.4%

10.8M shares

FMR LLC

SC 13G/A · Feb 12, 2025

15.0%

14.1M shares

Redmile Group, LLC

SC 13G/A · Nov 15, 2024

9.9%

8.3M shares

OrbiMed Capital LLC

SC 13G/A · Nov 15, 2024

0.6%

503K shares

10.8%

8.7M shares

The Vanguard Group

SC 13G/A · Nov 12, 2024

5.0%

4.0M shares

FMR LLC

SC 13G/A · Nov 12, 2024

13.3%

10.7M shares

The Vanguard Group

SC 13G/A · Nov 4, 2024

5.0%

4.0M shares

Samsara BioCapital, L.P.

SC 13D/A · Oct 8, 2024

8.2%

6.7M shares

Invus Public Equities, L.P.

SC 13G/A · Jul 29, 2024

15.8%

12.8M shares

OrbiMed Capital LLC

SC 13G · Feb 15, 2024

4.1%

3.0M shares

Redmile Group, LLC

SC 13G/A · Feb 14, 2024

9.9%

7.7M shares

12.3%

9.0M shares

Invus Public Equities, L.P. 2

SC 13G/A · Feb 9, 2024

17.4%

1.3B shares

BlackRock, Inc.

SC 13G · Jan 26, 2024

6.9%

5.0M shares

Samsara BioCapital, L.P.

SC 13D/A · Oct 18, 2023

11.0%

7.9M shares

Samsara BioCapital, L.P.

SC 13D · Feb 14, 2023

10.7%

5.7M shares

Redmile Group, LLC

SC 13G/A · Feb 14, 2023

9.9%

5.5M shares

BB Biotech AG

SC 13G/A · Feb 14, 2023

4.1%

2.1M shares

14.7%

7.7M shares

Invus Public Equities, L.P.

SC 13G/A · Feb 11, 2023

19.8%

10.6M shares

Redmile Group, LLC

SC 13G/A · Nov 18, 2022

9.9%

5.5M shares

BlackRock, Inc.

SC 13G · Jul 8, 2022

2.1%

1.1M shares

Redmile Group, LLC

SC 13G/A · Jun 27, 2022

9.9%

5.4M shares

Invus Public Equities, L.P.

SC 13G/A · Jun 24, 2022

19.4%

10.3M shares

Redmile Group, LLC

SC 13G/A · Feb 14, 2022

9.9%

3.6M shares

14.9%

5.3M shares

BB Biotech AG

SC 13G/A · Feb 11, 2022

6.5%

2.3M shares

Polaris Venture Partners VI, L.P.

SC 13G/A · Feb 11, 2022

6.9%

2.4M shares

Invus Public Equities, L.P.

SC 13G/A · Feb 11, 2022

7.0%

2.5M shares

View on Google Finance →